Internal Medicine, ISSN 0918-2918, 2017, Volume 56, Issue 14, pp. 1893 - 1896
A 25-year-old woman presenting with progressive muscle weakness in the distal extremities in the absence of sensory involvement for 2 years was diagnosed with...
multifocal motor neuropathy (MMN) | cyclophosphamide | Cyclophosphamide | Multifocal motor neuropathy (MMN) | NEUROLOGICAL SOCIETIES | TRIAL | 1ST REVISION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CONDUCTION BLOCK | PERIPHERAL-NERVE SOCIETY | JOINT TASK-FORCE | EUROPEAN FEDERATION | GUIDELINE | Cyclophosphamide - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Polyneuropathies - drug therapy | Mesna - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Cystitis - drug therapy | Administration, Intravenous | Mesna - adverse effects | Muscle Weakness | Adult | Female | Immunosuppressive Agents - adverse effects | Immunosuppressive Agents - administration & dosage | Mesna - administration & dosage | Therapy | Intravenous administration | Bladder | Muscles | Neuropathy | Hemorrhage | Disease control | Immunosuppressive agents | Urinary bladder | Perfusion | Ventilation | Hemorrhagic cystitis | Cystitis | Extremities | Long-term effects | Case Report
multifocal motor neuropathy (MMN) | cyclophosphamide | Cyclophosphamide | Multifocal motor neuropathy (MMN) | NEUROLOGICAL SOCIETIES | TRIAL | 1ST REVISION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CONDUCTION BLOCK | PERIPHERAL-NERVE SOCIETY | JOINT TASK-FORCE | EUROPEAN FEDERATION | GUIDELINE | Cyclophosphamide - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Polyneuropathies - drug therapy | Mesna - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Cystitis - drug therapy | Administration, Intravenous | Mesna - adverse effects | Muscle Weakness | Adult | Female | Immunosuppressive Agents - adverse effects | Immunosuppressive Agents - administration & dosage | Mesna - administration & dosage | Therapy | Intravenous administration | Bladder | Muscles | Neuropathy | Hemorrhage | Disease control | Immunosuppressive agents | Urinary bladder | Perfusion | Ventilation | Hemorrhagic cystitis | Cystitis | Extremities | Long-term effects | Case Report
Journal Article
2.
Full Text
Spreading of amyotrophic lateral sclerosis lesions—multifocal hits and local propagation?
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 01/2014, Volume 85, Issue 1, pp. 85 - 91
Objective To investigate whether or not the lesions in sporadic amyotrophic lateral sclerosis (ALS) originate from a single focal onset site and spread...
SURVIVAL | SURGERY | DIAGNOSIS | LOCALIZATION | PSYCHIATRY | SENSITIVITY | VULNERABILITY | SYMPTOMS | CLINICAL NEUROLOGY | MOTOR | AWAJI ALS CRITERIA | PARASPINAL MUSCLES | ONSET | Data Interpretation, Statistical | Motor Neurons - physiology | Humans | Middle Aged | Male | Disease Progression | Amyotrophic Lateral Sclerosis - pathology | Aged, 80 and over | Adult | Female | Aged | Electromyography | Muscle, Skeletal - pathology | Amyotrophic lateral sclerosis | Development and progression | Usage
SURVIVAL | SURGERY | DIAGNOSIS | LOCALIZATION | PSYCHIATRY | SENSITIVITY | VULNERABILITY | SYMPTOMS | CLINICAL NEUROLOGY | MOTOR | AWAJI ALS CRITERIA | PARASPINAL MUSCLES | ONSET | Data Interpretation, Statistical | Motor Neurons - physiology | Humans | Middle Aged | Male | Disease Progression | Amyotrophic Lateral Sclerosis - pathology | Aged, 80 and over | Adult | Female | Aged | Electromyography | Muscle, Skeletal - pathology | Amyotrophic lateral sclerosis | Development and progression | Usage
Journal Article
Molecular Therapy, ISSN 1525-0016, 04/2008, Volume 16, Issue 4, pp. 734 - 740
RNA interference is a powerful tool for target-specific knockdown of gene expression. However, efficient and safe delivery of short interfering RNA (siRNA) to...
MEDICINE, RESEARCH & EXPERIMENTAL | SMALL INTERFERING RNA | CELLS | VITAMIN-E | TRANSPORT | DESIGN | POTENT | GENE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | MICE | RNA, Small Interfering - genetics | Apolipoproteins B - metabolism | Liver - metabolism | Gene Silencing | alpha-Tocopherol | Apolipoproteins B - genetics | RNA, Messenger - metabolism | Drug Carriers | Animals | Cell Line, Tumor | Interferons - metabolism | Mice | RNA, Small Interfering - administration & dosage
MEDICINE, RESEARCH & EXPERIMENTAL | SMALL INTERFERING RNA | CELLS | VITAMIN-E | TRANSPORT | DESIGN | POTENT | GENE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | MICE | RNA, Small Interfering - genetics | Apolipoproteins B - metabolism | Liver - metabolism | Gene Silencing | alpha-Tocopherol | Apolipoproteins B - genetics | RNA, Messenger - metabolism | Drug Carriers | Animals | Cell Line, Tumor | Interferons - metabolism | Mice | RNA, Small Interfering - administration & dosage
Journal Article
The Lancet Neurology, ISSN 1474-4422, 06/2018, Volume 17, Issue 6, pp. 519 - 529
Despite the introduction of plasmapheresis and immunoglobulin therapy, many patients with Guillain-Barré syndrome still have an incomplete recovery. Evidence...
ANTIBODIES | COMPLEMENT | INHIBITION | NEUROPATHY | INTRAVENOUS IMMUNOGLOBULIN | SCALE | CLINICAL NEUROLOGY | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Guillain-Barre Syndrome - drug therapy | Humans | Japan | Middle Aged | Male | Treatment Outcome | Motor Activity | Recovery of Function | Adult | Female | Aged | Guillain-Barre syndrome | Clinical trials | Analysis | Immunoglobulins | Intravenous administration | Infections | Complement | Hemorrhage | Plasmapheresis | Studies | Anaphylaxis | Complement component C5 | Monoclonal antibodies | Ventilation | Safety
ANTIBODIES | COMPLEMENT | INHIBITION | NEUROPATHY | INTRAVENOUS IMMUNOGLOBULIN | SCALE | CLINICAL NEUROLOGY | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Guillain-Barre Syndrome - drug therapy | Humans | Japan | Middle Aged | Male | Treatment Outcome | Motor Activity | Recovery of Function | Adult | Female | Aged | Guillain-Barre syndrome | Clinical trials | Analysis | Immunoglobulins | Intravenous administration | Infections | Complement | Hemorrhage | Plasmapheresis | Studies | Anaphylaxis | Complement component C5 | Monoclonal antibodies | Ventilation | Safety
Journal Article
Diabetology and Metabolic Syndrome, ISSN 1758-5996, 09/2018, Volume 10, Issue 1, pp. 69 - 8
Background: It remains unclear whether glycemic variability is related to diabetes microvascular disease, especially diabetes peripheral neuropathy (DPN). We...
Continuous glucose monitoring | Nerve conduction study | Diabetes peripheral neuropathy | Glycemic variability | CARDIOVASCULAR AUTONOMIC NEUROPATHY | OXIDATIVE STRESS | EXCURSIONS | ACTIVATION | GLUCOSE VARIABILITY | PREVALENCE | RISK-FACTOR | ENDOCRINOLOGY & METABOLISM | PERIPHERAL NEUROPATHY | RETINOPATHY | COMPLICATIONS | Complications and side effects | Control | Care and treatment | Blood sugar | Analysis | Diabetes | Quality of life
Continuous glucose monitoring | Nerve conduction study | Diabetes peripheral neuropathy | Glycemic variability | CARDIOVASCULAR AUTONOMIC NEUROPATHY | OXIDATIVE STRESS | EXCURSIONS | ACTIVATION | GLUCOSE VARIABILITY | PREVALENCE | RISK-FACTOR | ENDOCRINOLOGY & METABOLISM | PERIPHERAL NEUROPATHY | RETINOPATHY | COMPLICATIONS | Complications and side effects | Control | Care and treatment | Blood sugar | Analysis | Diabetes | Quality of life
Journal Article
European Neurology, ISSN 0014-3022, 03/2018, Volume 79, Issue 1-2, pp. 27 - 32
Objective: We studied autonomic disturbance in patients with dementia with Lewy bodies (DLB), Parkinson disease with dementia (PDD), Alzheimer disease (AD), to...
Original Paper | autonomic function tests | Parkinson disease with dementia | Alzheimer disease | Dementia with Lewy bodies | SYMPATHETIC SKIN-RESPONSE | CLINICAL-DIAGNOSIS | BODY-DISEASE | FAILURE | NEUROSCIENCES | CLINICAL NEUROLOGY | Autonomic Nervous System Diseases - epidemiology | Parkinson Disease - complications | Autonomic Nervous System Diseases - etiology | Alzheimer Disease - complications | Humans | Dementia - diagnosis | Male | Autonomic Nervous System - physiopathology | Alzheimer Disease - diagnosis | Dementia - etiology | Parkinson Disease - diagnosis | Female | Aged | Tilt-Table Test
Original Paper | autonomic function tests | Parkinson disease with dementia | Alzheimer disease | Dementia with Lewy bodies | SYMPATHETIC SKIN-RESPONSE | CLINICAL-DIAGNOSIS | BODY-DISEASE | FAILURE | NEUROSCIENCES | CLINICAL NEUROLOGY | Autonomic Nervous System Diseases - epidemiology | Parkinson Disease - complications | Autonomic Nervous System Diseases - etiology | Alzheimer Disease - complications | Humans | Dementia - diagnosis | Male | Autonomic Nervous System - physiopathology | Alzheimer Disease - diagnosis | Dementia - etiology | Parkinson Disease - diagnosis | Female | Aged | Tilt-Table Test
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 2011, Volume 122, Issue 8, pp. e9 - e9
Journal Article
Muscle & Nerve, ISSN 0148-639X, 02/2011, Volume 43, Issue 2, pp. 274 - 282
In this study we aim to establish a motor nerve conduction study (NCS) for the cauda equina and examine its usefulness in multifocal motor neuropathy (MMN) and...
multifocal motor neuropathy | amyotrophic lateral sclerosis | high‐voltage electrical stimulation | cauda equina | multifocal motor neuropathy without conduction block | Multifocal motor neuropathy | Amyotrophic lateral sclerosis | High-voltage electrical stimulation | Multifocal motor neuropathy without conduction block | Cauda equina | PATHWAYS | CRITERIA | VELOCITY | DIAGNOSIS | BLOCK | high-voltage electrical stimulation | POTENTIALS | NEUROSCIENCES | CLINICAL NEUROLOGY | CENTRAL SEGMENT | MAGNETIC STIMULATION | F-WAVE | DOUBLE-BLIND | Cauda Equina - physiology | Electric Stimulation | Amyotrophic Lateral Sclerosis - therapy | Humans | Middle Aged | Hip - innervation | Male | Neural Conduction - physiology | Cauda Equina - physiopathology | Polyneuropathies - therapy | Magnetics | Action Potentials - physiology | Young Adult | Tibial Nerve - physiopathology | Knee - innervation | Ankle - innervation | Muscle, Skeletal - physiopathology | Aged, 80 and over | Adult | Female | Aged | Electromyography - methods
multifocal motor neuropathy | amyotrophic lateral sclerosis | high‐voltage electrical stimulation | cauda equina | multifocal motor neuropathy without conduction block | Multifocal motor neuropathy | Amyotrophic lateral sclerosis | High-voltage electrical stimulation | Multifocal motor neuropathy without conduction block | Cauda equina | PATHWAYS | CRITERIA | VELOCITY | DIAGNOSIS | BLOCK | high-voltage electrical stimulation | POTENTIALS | NEUROSCIENCES | CLINICAL NEUROLOGY | CENTRAL SEGMENT | MAGNETIC STIMULATION | F-WAVE | DOUBLE-BLIND | Cauda Equina - physiology | Electric Stimulation | Amyotrophic Lateral Sclerosis - therapy | Humans | Middle Aged | Hip - innervation | Male | Neural Conduction - physiology | Cauda Equina - physiopathology | Polyneuropathies - therapy | Magnetics | Action Potentials - physiology | Young Adult | Tibial Nerve - physiopathology | Knee - innervation | Ankle - innervation | Muscle, Skeletal - physiopathology | Aged, 80 and over | Adult | Female | Aged | Electromyography - methods
Journal Article
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, ISSN 0021-5384, 12/2008, Volume 97, Issue 12, p. 2998
Journal Article
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, ISSN 0021-5384, 12/2008, Volume 97, Issue 12, pp. 2998 - 3005
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 2008, Volume 119, Issue 6, pp. e87 - e88
Journal Article
Nihon Naika Gakkai Zasshi, ISSN 0021-5384, 2008, Volume 97, Issue 12, pp. 2998 - 3005
Journal Article
Clinical Neurology, ISSN 0009-918X, 2012, Volume 52, Issue 11, pp. 1059 - 1061
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 2009, Volume 120, Issue 5, pp. e178 - e178
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 2004, Volume 321, Issue 4, pp. 961 - 966
Bax is a proapoptotic protein that plays a key role in the induction of apoptosis. Ku70 has activities to repair DNA damage in the nucleus and to suppress...
Ku70 | Bax | Bax inhibiting peptide | Apoptosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | apoptosis | IDENTIFICATION | MATURATION | CONFORMATIONS | CYTOCHROME-C | BIOPHYSICS | NEURONAL DEATH | FOLLICLE-STIMULATING-HORMONE | SURVIVAL SIGNALS | CUMULUS CELLS | OOCYTES | Antigens, Nuclear - metabolism | Apoptosis - drug effects | Humans | Molecular Sequence Data | Ovary - cytology | DNA-Binding Proteins - metabolism | Antigens, Nuclear - chemistry | Female | Ovary - drug effects | Oligopeptides - chemistry | Ovary - metabolism | Proto-Oncogene Proteins - metabolism | Amino Acid Sequence | Cell Line | Proto-Oncogene Proteins - antagonists & inhibitors | Cells, Cultured | Etoposide - pharmacology | Rats | Oligopeptides - metabolism | bcl-2-Associated X Protein | DNA-Binding Proteins - genetics | DNA-Binding Proteins - chemistry | Sequence Homology, Amino Acid | Animals | Antigens, Nuclear - genetics | Ku Autoantigen | Mice | Proto-Oncogene Proteins c-bcl-2 | Oligopeptides - pharmacology | Peptides | Cell death | Universities and colleges
Ku70 | Bax | Bax inhibiting peptide | Apoptosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | apoptosis | IDENTIFICATION | MATURATION | CONFORMATIONS | CYTOCHROME-C | BIOPHYSICS | NEURONAL DEATH | FOLLICLE-STIMULATING-HORMONE | SURVIVAL SIGNALS | CUMULUS CELLS | OOCYTES | Antigens, Nuclear - metabolism | Apoptosis - drug effects | Humans | Molecular Sequence Data | Ovary - cytology | DNA-Binding Proteins - metabolism | Antigens, Nuclear - chemistry | Female | Ovary - drug effects | Oligopeptides - chemistry | Ovary - metabolism | Proto-Oncogene Proteins - metabolism | Amino Acid Sequence | Cell Line | Proto-Oncogene Proteins - antagonists & inhibitors | Cells, Cultured | Etoposide - pharmacology | Rats | Oligopeptides - metabolism | bcl-2-Associated X Protein | DNA-Binding Proteins - genetics | DNA-Binding Proteins - chemistry | Sequence Homology, Amino Acid | Animals | Antigens, Nuclear - genetics | Ku Autoantigen | Mice | Proto-Oncogene Proteins c-bcl-2 | Oligopeptides - pharmacology | Peptides | Cell death | Universities and colleges
Journal Article
Rinsho shinkeigaku = Clinical neurology, 2012, Volume 52, Issue 11, p. 1059
Using clinical information, it was investigated whether lesions in sporadic amyotrophic lateral sclerosis (sALS) spread contiguously from an onset site to the...
Amyotrophic Lateral Sclerosis - pathology | Humans | Disease Progression
Amyotrophic Lateral Sclerosis - pathology | Humans | Disease Progression
Journal Article
Molecular Therapy, ISSN 1525-0016, 04/2008, Volume 16, Issue 4, p. 734
RNA interference is a powerful tool for target-specific knockdown of gene expression. However, efficient and safe in vivo delivery of short interfering RNA...
Journal Article
Molecular therapy : the journal of the American Society of Gene Therapy, ISSN 1525-0016, 04/2008, Volume 16, Issue 4, p. 734
RNA interference is a powerful tool for target-specific knockdown of gene expression. However, efficient and safe in vivo delivery of short interfering RNA...
Journal Article
Journal of Neurology, ISSN 0340-5354, 5/2008, Volume 255, Issue 5, pp. 773 - 774
Neurology | Neurosciences | Medicine & Public Health | Neuroradiology | SECONDARY | BARR VIRUS-INFECTION | CLINICAL NEUROLOGY | Diagnosis, Differential | Humans | Retina - physiopathology | Hemianopsia - diagnosis | Treatment Outcome | Optic Neuritis - diagnosis | Demyelinating Autoimmune Diseases, CNS - diagnosis | Optic Chiasm - physiopathology | Magnetic Resonance Imaging | Optic Neuritis - physiopathology | Visual Fields | Mumps - complications | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Hemianopsia - physiopathology | Optic Neuritis - pathology | Optic Chiasm - pathology | Methylprednisolone - administration & dosage | Parotitis - complications
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 06/1997, Volume 62, Issue 6, pp. 629 - 632
The mechanism of mirror movements in two patients was investigated; one with congenital mirror movement, the other with schizencephaly. Transcranial magnetic...
Mirror movement | Transcranial magnetic stimulation | Silent period | O-PET | PATHWAYS | SURGERY | (H2O)-O-15-PET | silent period | PSYCHIATRY | mirror movement | transcranial magnetic stimulation | CLINICAL NEUROLOGY | Motor Cortex - physiology | Humans | Adolescent | Dominance, Cerebral | Adult | Male | Electromyography | Tomography, Emission-Computed
Mirror movement | Transcranial magnetic stimulation | Silent period | O-PET | PATHWAYS | SURGERY | (H2O)-O-15-PET | silent period | PSYCHIATRY | mirror movement | transcranial magnetic stimulation | CLINICAL NEUROLOGY | Motor Cortex - physiology | Humans | Adolescent | Dominance, Cerebral | Adult | Male | Electromyography | Tomography, Emission-Computed
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.